Conventional drug delivery systems face several issues in medical applications, such as cyto/genotoxicity and off-targeting. These issues are particularly significant for cancer therapeutics because many of the currently used systems are toxic in their free form. Self-propelled autonomous micro/nanomachines offer promising alternative drug delivery systems based on high cargo loading, fast autonomous movement, precise targeting and the on-demand release of therapeutics in vivo. With this unique set of properties, it is not surprising that they are receiving considerable research attention. However, much less is reported about the drawbacks that hinder their systemic in vivo application. In this review, a biomedical perspective is used to assess micro/nanomotor-based anticancer drug delivery systems reported to date. Advantages along with present issues are highlighted and recommendations which need to be considered to develop an effective biocompatible micro/nanomotor-based delivery system for cancer therapy are discussed.
Aliphatic poly(ester-carbonates) are receiving extensive research attention as tailorable materials suitable for multiple applications from tissue engineering and 3D scaffold printing to drug delivery. Thus, simple reliable procedures for producing easily tailorable poly(ester-carbonates) without metal residues are continuously sought after. In this work, we report on one-pot synthesis of random copolymers of TMC and δ-VL using metal-free biocompatible 1,5,7-triazabicyclo[4.4.0]dec-5-ene as a catalyst and benzyl alcohol and poly(ethylene oxide) as initiators. Random poly(ester-carbonates) with TMC : VL unit ratios ranging from 80 : 20 to 20 : 80 were synthesized via ring-opening polymerization while displaying excellent agreement of comonomers' ratios in the feed and copolymer chains. The copolymers' supramolecular structure, thermal and mechanical properties were thoroughly analyzed by various methods. The obtained results clearly indicated that the physicochemical properties can be controlled simply by varying the ratio of comonomers and the length of segments in the copolymer chain. Several copolymers exhibited behavior of thermoplastic elastomers with the most promising one exhibiting a 2200% increase in elongation at break compared to the poly(valerolactone) homopolymer while retaining tensile strength and Young's modulus suitable for biomedical applications. Overall, our work contributed to widening the portfolio of tailorable copolymers for specialized bioapplications and possibly paving a way for the use of more sustainable polymers in the biomedical field.